Literature DB >> 29984108

Visualization of drug distribution of a topical minocycline gel in human facial skin.

Sinyoung Jeong1, Maiko Hermsmeier2, Sam Osseiran1,3, Akira Yamamoto2, Usha Nagavarapu2, Kin F Chan2, Conor L Evans1.   

Abstract

Acne vulgaris is a common chronic skin disease in young adults caused by infection of the pilosebaceous unit, resulting in pimples and possibly permanent scarring on the skin. Minocycline, a common antibiotic, has been widely utilized as a systemic antimicrobial treatment for acne via oral administration. Recently, a topical minocycline gel (BPX-01) was developed to directly deliver minocycline through the epidermis and into the pilosebaceous unit to achieve localized treatment with lower doses of drug. As the effectiveness of the drug is directly related to its successful delivery, there is a need to evaluate the pharmacokinetics at the cellular level within tissue. Advantageously, minocycline is naturally fluorescent and can be directly visualized using microscopy-based approaches. Due to high endogenous autofluorescence, however, imaging of weakly emitting fluorescent molecules such as minocycline in skin tissue can be challenging. Here, we demonstrate a method for the selective visualization of minocycline within human skin tissue by utilizing two-photon excitation fluorescence (TPEF) microscopy and fluorescence lifetime imaging microscopy (FLIM). To demonstrate the feasibility of this approach, ex vivo human facial skin samples treated with various concentrations of BPX-01 were investigated. From the TPEF analysis, we were able to visualize relatively high levels of drug uptake within facial skin. However, minocycline fluorescence could be overwhelmed by endogenous fluorescence that complicates TPEF quantitative analysis, making FLIM more advantageous for visualizing drug uptake. Importantly, we found a unique signature of minocycline uptake via FLIM analysis that enabled the successful differentiation of the drug and enabled the extraction of drug local distribution from the endogenous fluorescence using a non-Euclidean phasor analysis method. Based on these results, we believe that the drug local distribution visualization method using TPEF and FLIM with phasor analysis can play an important role in studying the pharmacokinetics and pharmacodynamics of a topically applicable drug.

Entities:  

Keywords:  (100.0100) Image processing; (170.0170) Medical optics and biotechnology; (170.1870) Dermatology; (180.0180) Microscopy; (190.4180) Multiphoton processes

Year:  2018        PMID: 29984108      PMCID: PMC6033575          DOI: 10.1364/BOE.9.003434

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  24 in total

1.  Visualization of oleic acid-induced transdermal diffusion pathways using two-photon fluorescence microscopy.

Authors:  Betty Yu; Ki Hean Kim; Peter T C So; Daniel Blankschtein; Robert Langer
Journal:  J Invest Dermatol       Date:  2003-03       Impact factor: 8.551

Review 2.  Applications of multiphoton tomographs and femtosecond laser nanoprocessing microscopes in drug delivery research.

Authors:  Karsten König; Anthony P Raphael; Li Lin; Jeffrey E Grice; H Peter Soyer; H Georg Breunig; Michael S Roberts; Tarl W Prow
Journal:  Adv Drug Deliv Rev       Date:  2011-04-13       Impact factor: 15.470

3.  In situ analysis of tyrosine phosphorylation networks by FLIM on cell arrays.

Authors:  Hernán E Grecco; Pedro Roda-Navarro; Andreas Girod; Jian Hou; Thomas Frahm; Dina C Truxius; Rainer Pepperkok; Anthony Squire; Philippe I H Bastiaens
Journal:  Nat Methods       Date:  2010-05-09       Impact factor: 28.547

Review 4.  Deep tissue two-photon microscopy.

Authors:  Fritjof Helmchen; Winfried Denk
Journal:  Nat Methods       Date:  2005-12       Impact factor: 28.547

Review 5.  Principles of two-photon excitation microscopy and its applications to neuroscience.

Authors:  Karel Svoboda; Ryohei Yasuda
Journal:  Neuron       Date:  2006-06-15       Impact factor: 17.173

6.  The phasor approach to fluorescence lifetime imaging analysis.

Authors:  Michelle A Digman; Valeria R Caiolfa; Moreno Zamai; Enrico Gratton
Journal:  Biophys J       Date:  2007-11-02       Impact factor: 4.033

7.  In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia.

Authors:  Melissa C Skala; Kristin M Riching; Annette Gendron-Fitzpatrick; Jens Eickhoff; Kevin W Eliceiri; John G White; Nirmala Ramanujam
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

8.  Autofluorescence spectrum of skin: component bands and body site variations.

Authors:  Renhua Na; Ida-Marie Stender; Lixin Ma; Hans Christian Wulf
Journal:  Skin Res Technol       Date:  2000-08       Impact factor: 2.365

9.  Autofluorescence of human skin is age-related after correction for skin pigmentation and redness.

Authors:  R Na; I M Stender; M Henriksen; H C Wulf
Journal:  J Invest Dermatol       Date:  2001-04       Impact factor: 8.551

10.  Phasor fluorescence lifetime microscopy of free and protein-bound NADH reveals neural stem cell differentiation potential.

Authors:  Chiara Stringari; Jamison L Nourse; Lisa A Flanagan; Enrico Gratton
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

View more
  2 in total

1.  Characterization of human cutaneous tissue autofluorescence: implications in topical drug delivery studies with fluorescence microscopy.

Authors:  Maiko Hermsmeier; Sinyoung Jeong; Akira Yamamoto; Xin Chen; Usha Nagavarapu; Conor L Evans; Kin F Chan
Journal:  Biomed Opt Express       Date:  2018-10-12       Impact factor: 3.732

Review 2.  Imaging and quantifying drug delivery in skin - Part 2: Fluorescence andvibrational spectroscopic imaging methods.

Authors:  Ana-Maria Pena; Xueqin Chen; Isaac J Pence; Thomas Bornschlögl; Sinyoung Jeong; Sébastien Grégoire; Gustavo S Luengo; Philippe Hallegot; Peyman Obeidy; Amin Feizpour; Kin F Chan; Conor L Evans
Journal:  Adv Drug Deliv Rev       Date:  2020-03-23       Impact factor: 15.470

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.